iBankCoin
18 years in Wall Street, left after finding out it was all horseshit. Founder/ Master and Commander: iBankCoin, finance news and commentary from the future.
Joined Nov 10, 2007
23,417 Blog Posts

ANNIHILATE THEM!

You do the math.

Bad jobs markets equals no more Fed speeches menacing us with rate hike suggestions.

Today’s’ price action was capitulation. It also lured a fresh set of bears into the fray.

The perfect trap.

Up we go. Prepare to behead the heads of your enemies.

Top picks: BIDU, GG, SHAK, CLX, TWTR, AMCX

If you enjoy the content at iBankCoin, please follow us on Twitter

13 comments

  1. pb

    In Darth Vader voice: “Do not underestimate the power of The Bear.”

    • 0
    • 0
    • 0 Deem this to be "Fake News"
  2. djmarcus

    @fly, did you see the holmes movie? how was it?

    • 0
    • 0
    • 0 Deem this to be "Fake News"
  3. Dr. Fly

    It was good

    • 0
    • 0
    • 0 Deem this to be "Fake News"
  4. paradox

    Not to quibble but, it’s redundant to say ‘behead the heads’…

    • 0
    • 0
    • 0 Deem this to be "Fake News"
    • Dr. Fly

      I know. Lots of things I write are grammatically incorrect. I take artistic license.

      • 0
      • 0
      • 0 Deem this to be "Fake News"
  5. the dude

    My four horsemen – TQQQ, IBB, FCX, CHK – and their Indian sidekick EROS will slaughter hundreds of bears this quarter. There will be blood.

    • 0
    • 0
    • 0 Deem this to be "Fake News"
  6. superpositron

    Long. Full commitment.

    • 0
    • 0
    • 0 Deem this to be "Fake News"
  7. Marc David

    Da Bears!

    • 0
    • 0
    • 0 Deem this to be "Fake News"
  8. pb

    Nice NYT hit piece on VRX: http://www.nytimes.com/2015/10/04/business/valeants-high-price-drug-strategy.html

    “One argument for high prices on pharmaceuticals is that the money goes to research for new cures. But this is not a Valeant strategy.

    While other multinational pharmaceutical companies spend well into the double digits as a percentage of sales, Valeant’s 2014 annual report shows that the company spent $246 million on research and development — just 3 percent of sales. Another way to think about that: Valeant paid its five highest-paid executives 1.5 percent of sales, or $123 million, last year.”

    • 0
    • 0
    • 0 Deem this to be "Fake News"
  9. it is showtime

    Bad jobs
    Deflationary vortex
    Rebubbling a revealed bubbled biotech

    EMPEROR BEING SHOWN W NO CLOTHES

    • 0
    • 0
    • 0 Deem this to be "Fake News"
  10. zuulgetsloggedouteveryday
    zuulgetsloggedouteveryday

    bought spy calls on wed. sold them wed at mkt close. bought qqq calls yesterday during the afternoon slump, holding. bought spy calls this morning when the mkt was [lol] down 30pts.

    doubt we make new highs, but imo we go higher than the post fed surge.

    • 0
    • 0
    • 0 Deem this to be "Fake News"